A phase 1/2, first-in-human study of STX-478 monotherapy or in combination with fulvestrant in patients with breast cancer or other advanced solid tumors (trial in progress)

被引：0
|
作者：
Montero, Alberto
Orr, Douglas
Munster, Pamela
LoRusso, Patricia
Jhaveri, Komal
Pluard, Timothy
Winer, Ira
Streit, Michael
Patterson, Monica
Roberts, Simon
Corsi-Travali, Stefani
Ewert, Courtney
Juric, Dejan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-20-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-20-04
引用
收藏
页数：4
相关论文
共 50 条
  • [1] First-in-human results of STX-478, a mutant-selective PI3Ka inhibitor, in advanced solid tumor patients
    Montero, A. J.
    Giordano, A.
    Jhaveri, K.
    Munster, P.
    Rodon, J.
    Lorusso, P.
    Orr, D.
    Bartolome Arcilla, J.
    Italiano, A.
    Elias, A.
    Soyano, A.
    De Miguel, M.
    Doger de Speville, B.
    Daniele, G.
    O'Shaughnessy, J.
    Hernandez Guerrero, T. C.
    Wesolowski, R.
    Saura Manich, C.
    Chao, M.
    Juric, D.
    ANNALS OF ONCOLOGY, 2024, 35 : 1220 - 1220
  • [2] First-in-human study of ABBV-514 as monotherapy and in combination with budigalimab in patients with advanced solid tumors
    Babu, S.
    Kondo, S.
    Ammakkanavar, N.
    Spira, A. I.
    Perets, R.
    Doi, T.
    Bar, J.
    Vandross, A.
    Sommerhalder, D.
    Nikolic, V.
    Tribouley, C.
    Atluri, H.
    Hong, J.
    Paustian, A.
    Leibman, R.
    Powderly, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S647 - S648
  • [3] Trial in progress: Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumors
    Kummar, Shivaani
    Barve, Minal
    Feldman, Eric
    Ma, Seunghyun
    Merchan, Jaime
    Im, Seock-Ah
    Rha, Sun Young
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [4] Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors.
    Powderly, John
    Shimizu, Toshio
    LoRusso, Patricia
    Razak, Albiruni
    Miller, Kathy
    Balar, Arjun
    Bruix, Jordi
    Michel, Loren
    Blaney, Martha
    Guan, Xiaowen
    Lacy, Susan
    Lally, Satwant
    Lambert, Stacie
    Leibman, Rachel
    Vosganian, Gregory
    Golan, Talia
    Tolcher, Anthony
    CANCER RESEARCH, 2021, 81 (13)
  • [5] TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial
    Naing, Aung
    Mckean, Meredith
    Tolcher, Anthony
    Victor, Anja
    Hu, Ping
    Gao, Wei
    Filho, Marco A. F. Nogueira
    Kitzing, Thomas
    Gleicher, Stephan
    Holland, Daniel
    Richter, Emilia
    Tadjalli-Mehr, Keyvan
    Siu, Lillian L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [6] First-in-human phase I study of ABBV-637 as monotherapy and in combination in patients with relapsed and refractory solid tumors
    Rotow, J.
    Yoh, K.
    Powderly, J. D.
    Shimizu, T.
    Perets, R.
    Paz-Ares, L.
    Phillips, A.
    Souers, A.
    Ansell, P. J.
    Jin, J.
    Badawi, M.
    Saab, R.
    Morrison-Thiele, G.
    Jeffries, S.
    Aristide, M. R. Neagu
    Carneiro, B. A.
    Papadopoulos, K. P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1090 - S1090
  • [7] TRIAL IN PROGRESS: PHASE 1 FIRST-IN-HUMAN STUDY OF XL092 ADMINISTERED ALONE OR IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
    Patnaik, Amita
    Subbiah, Vivek
    Shapiro, Geoffrey
    Pal, Sumanta
    Agarwal, Neeraj
    Wentzel, Kristopher
    Li, Jing
    McIlvaine, Elizabeth
    Waldes, Jana
    Cha, Edward
    Tadjalli-Mehr, Keyvan
    Sharma, Manish
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A544 - A544
  • [8] A phase 1/1b first-in-human (FIH) study of JZP898 as monotherapy and in combination with pembrolizumab in adult patients with advanced or metastatic solid tumors.
    McKean, Meredith
    Hutson, Thomas E.
    Piha-Paul, Sarina A.
    Micaily, Ida
    Liao, Mingxiang
    Humphreys, Robin
    Brock, Graham
    Sahr, Natasha
    Amber, Vian
    Spira, Alexander I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
    Hong, David S.
    Kurzrock, Razelle
    Supko, Jeffrey G.
    He, Xiaoying
    Naing, Aung
    Wheler, Jennifer
    Lawrence, Donald
    Eder, Joseph Paul
    Meyer, Colin J.
    Ferguson, Deborah A.
    Mier, James
    Konopleva, Marina
    Konoplev, Sergej
    Andreeff, Michael
    Kufe, Donald
    Lazarus, Hillard
    Shapiro, Geoffrey I.
    Dezube, Bruce J.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3396 - 3406
  • [10] First-in-human phase 1 study of DS-1062a in patients with advanced solid tumors.
    Sands, Jacob M.
    Shimizu, Toshio
    Garon, Edward B.
    Greenberg, Jonathan
    Guevara, Ferdinand M.
    Heist, Rebecca Suk
    Kobayashi, Fumiaki
    Noguchi, Yutaka
    Okajima, Daisuke
    Tajima, Naoyuki
    Spira, Alexander I.
    Yamamoto, Noboru
    Lisberg, Aaron Elliott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345